(Q34678977)

3 August 2017

1 reference

title

Reduction of animal use in human vaccine quality control: opportunities and problems (English)

1 reference

3 August 2017

0 references

3

Wim Jiskoot

1 reference

3 August 2017

4

Gideon F A Kersten

1 reference

3 August 2017

Bernard Metz

1

1 reference

3 August 2017

Coenraad F M Hendriksen

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

3 August 2017

number of pages

20

1 reference

inferred from page(s)

published in

Vaccine

1 reference

3 August 2017

volume

20

1 reference

3 August 2017

issue

19-20

1 reference

3 August 2017

page(s)

2411-2430

1 reference

A need to review regulations for production and control of vaccines

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Reduction of animal use: experimental design and quality of experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Is the test for abnormal toxicity, general safety or innocuity necessary for vaccines?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Elimination of abnormal toxicity test for sera and certain vaccines in the European Pharmacopoeia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. II. Comparison with the rabbit skin method and practical application for seroepidemiological studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

An investigation of a mouse model to estimate the potency of the diphtheria component in vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

A sensitive and rapid fluorescence-based assay for determination of tetanus toxin peptidase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Collaborative study on test systems to assess toxicity of whole cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Evaluation of the neurovirulence test for mumps vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Transgenic mice susceptible to poliovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Development of a transgenic mouse neurovirulence test for oral poliovirus vaccine: international collaborative study 1993-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Quantification of 2-keto-3-deoxyoctonate in (lipo)polysaccharides by methanolytic release, trifluoroacetylation and capillary gas chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Use of reverse transcriptase polymerase chain reaction for detection of vaccine contamination by avian leukosis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

1 reference

7 January 2021

A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

BIAcore for macromolecular interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Theoretical analysis of protein concentration determination using biosensor technology under conditions of partial mass transport limitation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Reliable determination of binding affinity and kinetics using surface plasmon resonance biosensors.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Biosensors in immunology: the story so far.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Concentration measurement of unpurified proteins using biosensor technology under conditions of partial mass transport limitation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Rapid monitoring of virus-like particles using an optical biosensor: a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Interpretation of deviations from pseudo-first-order kinetic behavior in the characterization of ligand binding by biosensor technology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Effect of adjuvant composition on immune response to a multiple antigen peptide (MAP) containing a protective epitope from Neisseria meningitidis class 1 porin.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Validation of peptide mapping for protein identity and genetic stability. Biologics and biotechnology section, pharmaceutical research and manufacturers of America

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Synthesis and characterization of Respiratory Syncytial Virus protein G related peptides containing two disulfide bridges

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Purification and characterization of a recombinant hepatitis E protein vaccine candidate by liquid chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Characterization of a Helicobacter pylori vaccine candidate by proteome techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Structural and functional characterization of a recombinant PorB class 2 protein from Neisseria meningitidis. Conformational stability and porin activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Characterization of the structure, function, and conformational stability of PorB class 3 protein from Neisseria meningitidis. A porin with unusual physicochemical properties

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

The role of mass spectrometry in vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Contributions of mass spectrometry to structural immunology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Antigenic surveillance of the influenza virus by mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Determination of free amino groups in proteins by trinitrobenzenesulfonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

A fluorometric assay of the degree of modification of protein primary amines with polyethylene glycol

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Molecular size characterization of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Comparison of in vitro and in vivo methods to study stability of PLGA microencapsulated tetanus toxoid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Size and conformational stability of the hepatitis A virus used to prepare VAQTA, a highly purified inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Physico-chemical analysis of Bordetella pertussis antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

An in vitro approach in quality control of toxoid vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Quantitative determination of saccharide in Haemophilus influenzae type b glycoconjugate vaccines, alone and in combination with DPT, by use of high-performance anion-exchange chromatography with pulsed amperometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Development of a new method for the quantitative analysis of the extracellular polysaccharide of Neisseria meningitidis serogroup A by use of high-performance anion-exchange chromatography with pulsed-amperometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Monosaccharide analysis of glycoconjugates by anion exchange chromatography with pulsed amperometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

High-performance liquid chromatography of sialic acid-containing oligosaccharides and acidic monosaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Quantification of polysaccharide in Haemophilus influenzae type b conjugate and polysaccharide vaccines by high-performance anion-exchange chromatography with pulsed amperometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Immunogenicity of various presentation forms of PorA outer membrane protein of Neisseria meningitidis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Spectroscopic methods for analysis of protein secondary structure

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Structural analysis of an outer surface protein from the Lyme disease spirochete, Borrelia burgdorferi, using circular dichroism and fluorescence spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Comparison of the diphtheria mutant toxin, CRM197, with a Haemophilus influenzae type-b polysaccharide-CRM197 conjugate by optical spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Physico-chemical and antigenic properties of tetanus and diphtheria toxoids and steps towards improved stability

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

The secondary structure and aggregation of lyophilized tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Polysaccharide coated liposomes for oral immunization--development and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Use and validation of an NMR test for the identity and O-acetyl content of the Salmonella typhi Vi capsular polysaccharide vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

An NMR spectroscopic identity test for the control of the capsular polysaccharide from Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Development and validation of an NMR-based identity assay for bacterial polysaccharides.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Full assignment of the proton and carbon NMR spectra and revised structure for the capsular polysaccharide from Streptococcus pneumoniae type 17F

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Optimal conditions for the generation of monoclonal antibodies using primary immunisation of mouse splenocytes in vitro under serum-free conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Rapid generation of monoclonal antibody-secreting hybridomas against African horse sickness virus by in vitro immunization and the fusion/cloning technique

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Influence of antigen presentation and exogenous cytokine activity during in vitro primary immunizations employed for the generation of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

The quantitative estimation of diphtheria and tetanus toxoids. 1. The flocculation test and the Lf-unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

A WHO Collaborative study on assays of the antigenic content of inactivated poliovirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Characterization of recombinant hepatitis B surface antigen using surface plasmon resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Liposomes as vehicles for the presentation of a synthetic peptide containing an epitope of hepatitis A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

DTaP vaccines from north american vaccine (NAVA): composition and critical parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM(197) conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Filamentous hemagglutinin of Bordetella pertussis. A bacterial adhesin formed as a 50-nm monomeric rigid rod based on a 19-residue repeat motif rich in beta strands and turns.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Comparison of the conformation, hydrophobicity, and model membrane interactions of diphtheria toxin to those of formaldehyde-treated toxin (diphtheria toxoid): formaldehyde stabilization of the native conformation inhibits changes that allow membran

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

Evaluation of transmission electron microscopy for examination of components of acellular pertussis and combination vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

The Pertussis Serological Potency Test. Collaborative study to evaluatereplacement of the Mouse Protection Test

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900192-5

7 January 2021

10.1016/S0264-410X(02)00192-5

Identifiers

DOI

1 reference

3 August 2017

1 reference